OGN

Organon & Co.

A global pharmaceutical company focused on women's health, with products from the contraceptive implant Nexplanon and the fertility drug Follistim AQ to biosimilars like Hadlima, sold across more than a hundred countries. The name comes from the Ancient Greek word for "an instrument for acquiring knowledge," the title of Aristotle's writings on logic. Founded in 1923 in the Netherlands to make insulin, the company was spun off from Merck in 2021, returning to its women's-health roots.